-
Fenofibrate suppresses melanogenesis in B16-F10 melanoma cells via activation of the p38 mitogen-activated protein kinase pathway.
Chemico-biological interactions 20131005
-
15-Deoxy-Δ(12,14)-prostaglandin J(2) attenuates the biological activities of monocyte/macrophage cell lines.
European journal of cell biology 20120801
-
Ciglitazone inhibits cigarette smoke solution-induced inflammatory responses in human middle ear epithelial cells.
International journal of pediatric otorhinolaryngology 20120801
-
Development of a novel class of glucose transporter inhibitors.
Journal of medicinal chemistry 20120426
-
COM-1/p8 acts as a tumour growth enhancer in colorectal cancer cell lines.
Anticancer research 20120401
-
Peroxisome proliferating activating receptor gamma-independent attenuation of interleukin 6 and interleukin 8 secretion from primary endometrial stromal cells by thiazolidinediones.
Fertility and sterility 20120301
-
The use of rat lens explant cultures to study the mechanism of drug-induced cataractogenesis.
Toxicological sciences : an official journal of the Society of Toxicology 20120301
-
Cell death is induced by ciglitazone, a peroxisome proliferator-activated receptor γ (PPARγ) agonist, independently of PPARγ in human glioma cells.
Biochemical and biophysical research communications 20120106
-
The modulation of PPARγ1 and PPARγ2 mRNA expression by ciglitazone in CD3/CD28-activated naïve and memory CD4+ T cells.
Clinical & developmental immunology 20120101
-
Danhong inhibits oxidized low-density lipoprotein-induced immune maturation of dentritic cells via a peroxisome proliferator activated receptor γ-mediated pathway.
Journal of pharmacological sciences 20120101
-
Proteome analysis identified the PPARγ ligand 15d-PGJ2 as a novel drug inhibiting melanoma progression and interfering with tumor-stroma interaction.
PloS one 20120101
-
15-deoxy-Δ(12,14) -prostaglandin-J2 and ciglitazone inhibit TNF-α-induced matrix metalloproteinase 13 production via the antagonism of NF-κB activation in human synovial fibroblasts.
Journal of cellular physiology 20111201
-
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
PLoS computational biology 20111201
-
Chemical genomics profiling of environmental chemical modulation of human nuclear receptors.
Environmental health perspectives 20110801
-
Lack of evidence of CD40 ligand involvement in transfusion-related acute lung injury.
Clinical and experimental immunology 20110801
-
SR-PSOX at sites predisposed to atherosclerotic lesion formation mediates monocyte-endothelial cell adhesion.
Atherosclerosis 20110801
-
Combination of ciglitazone, a peroxisome proliferator-activated receptor gamma ligand, and cisplatin enhances the inhibition of growth of human ovarian cancers.
Journal of cancer research and clinical oncology 20110801
-
Synthesis and biological evaluation of novel thiazolidinedione analogues as 15-hydroxyprostaglandin dehydrogenase inhibitors.
Journal of medicinal chemistry 20110728
-
Peroxisome proliferator-activated receptor-γ agonists prevent in vivo remodeling of human artery induced by alloreactive T cells.
Circulation 20110712
-
Stable reporter cell lines for peroxisome proliferator-activated receptor γ (PPARγ)-mediated modulation of gene expression.
Analytical biochemistry 20110701
-
PPARgamma activators stimulate aquaporin 3 expression in keratinocytes/epidermis.
Experimental dermatology 20110701
-
15-Deoxy-delta12,14-prostaglandin J2-glycerol ester, a putative metabolite of 2-arachidonyl glycerol, activates peroxisome proliferator activated receptor gamma.
Molecular pharmacology 20110701
-
Troglitazone suppresses c-Myc levels in human prostate cancer cells via a PPARγ-independent mechanism.
Cancer biology & therapy 20110615
-
[Effect of ciglitazone on THP-1 macrophage CD36 expression and cholesterol influx].
Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology 20110601
-
Combined treatment with TRAIL and PPARγ ligands overcomes chemoresistance of ovarian cancer cell lines.
Journal of cancer research and clinical oncology 20110501
-
Induction of apoptosis by 15d-PGJ2 via ROS formation: an alternative pathway without PPARγ activation in non-small cell lung carcinoma A549 cells.
Prostaglandins & other lipid mediators 20110401
-
Pigment epithelial-derived factor inhibits c-FLIP expression and assists ciglitazone-induced apoptosis in hepatocellular carcinoma.
Anticancer research 20110401
-
Energy restriction-mimetic agents induce apoptosis in prostate cancer cells in part through epigenetic activation of KLF6 tumor suppressor gene expression.
The Journal of biological chemistry 20110325
-
Combined treatment with the Cox-2 inhibitor niflumic acid and PPARγ ligand ciglitazone induces ER stress/caspase-8-mediated apoptosis in human lung cancer cells.
Cancer letters 20110128
-
Pioglitazone modulates tumor cell metabolism and proliferation in multicellular tumor spheroids.
Cancer chemotherapy and pharmacology 20110101
-
Peroxisome-proliferator-activated receptors γ and β/δ mediate vascular endothelial growth factor production in colorectal tumor cells.
Journal of cancer research and clinical oncology 20110101
-
Ciglitazone negatively regulates CXCL1 signaling through MITF to suppress melanoma growth.
Cell death and differentiation 20110101
-
Identification of clinically used drugs that activate pregnane X receptors.
Drug metabolism and disposition: the biological fate of chemicals 20110101
-
Specific thiazolidinediones inhibit ovarian cancer cell line proliferation and cause cell cycle arrest in a PPARγ independent manner.
PloS one 20110101
-
The antidiabetic drug ciglitazone induces high grade bladder cancer cells apoptosis through the up-regulation of TRAIL.
PloS one 20110101
-
The PPARγ ligand ciglitazone regulates androgen receptor activation differently in androgen-dependent versus androgen-independent human prostate cancer cells.
Experimental cell research 20101210
-
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Toxicological sciences : an official journal of the Society of Toxicology 20101201
-
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Drug metabolism and disposition: the biological fate of chemicals 20101201
-
RXRgamma and PPARgamma ligands in combination to inhibit proliferation and invasiveness in colon cancer cells.
Cancer letters 20101101
-
Activation of PPAR-γ and PTEN cascade participates in lovastatin-mediated accelerated differentiation of oligodendrocyte progenitor cells.
Glia 20101101
-
Expression and regulation of GPAT isoforms in cultured human keratinocytes and rodent epidermis.
Journal of lipid research 20101101
-
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
Bioorganic & medicinal chemistry letters 20101101
-
Identification of novel monoamine oxidase B inhibitors by structure-based virtual screening.
Bioorganic & medicinal chemistry letters 20100901
-
[Pro-apoptotic effect of ciglitazone in leukemic HL-60 cells via PPARγ and P38 MAPK signaling pathway].
Zhonghua yi xue za zhi 20100824
-
Tongxinluo inhibits oxidized low-density lipoprotein-induced maturation of human dendritic cells via activating peroxisome proliferator-activated receptor gamma pathway.
Journal of cardiovascular pharmacology 20100801
-
Peroxisome proliferator-activated receptor gamma promotes neuroprotection by modulating cyclin D1 expression after focal cerebral ischemia.
Canadian journal of physiology and pharmacology 20100701
-
Effect of BMP-9 and its derived peptide on the differentiation of human white preadipocytes.
Growth factors (Chur, Switzerland) 20100601
-
Thiazolidinediones decrease vascular endothelial growth factor (VEGF) production by human luteinized granulosa cells in vitro.
Fertility and sterility 20100401
-
The MAPK-dependent regulation of the Jagged/Notch gene expression by VEGF, bFGF or PPAR gamma mediated angiogenesis in HUVEC.
Journal of physiology and pharmacology : an official journal of the Polish Physiological Society 20100401
-
Development of novel adenosine monophosphate-activated protein kinase activators.
Journal of medicinal chemistry 20100325
-
PPARgamma regulates LIF-induced growth and self-renewal of mouse ES cells through Tyk2-Stat3 pathway.
Cellular signalling 20100301
-
Troglitazone inhibits histone deacetylase activity in breast cancer cells.
Cancer letters 20100227
-
Differential expression of peroxisome proliferator activated receptor gamma and cyclin D1 does not affect proliferation of asthma- and non-asthma-derived airway smooth muscle cells.
Respirology (Carlton, Vic.) 20100201
-
Opposite effects of two thiazolidinediones, ciglitazone and troglitazone, on proteinase-activated receptor-1-triggered prostaglandin E(2) release.
Toxicology 20100131
-
Liver apoptosis is age dependent and is reduced by activation of peroxisome proliferator-activated receptor-gamma in hemorrhagic shock.
American journal of physiology. Gastrointestinal and liver physiology 20100101
-
PPARgamma ligand 15-deoxy-delta 12,14-prostaglandin J2 sensitizes human colon carcinoma cells to TWEAK-induced apoptosis.
Anticancer research 20100101
-
Thiazolidinediones enhance vascular endothelial growth factor expression and induce cell growth inhibition in non-small-cell lung cancer cells.
Journal of experimental & clinical cancer research : CR 20100101
-
Synergism in hyperhomocysteinemia and diabetes: role of PPAR gamma and tempol.
Cardiovascular diabetology 20100101
-
Steroid receptor coactivator 1 deficiency increases MMTV-neu mediated tumor latency and differentiation specific gene expression, decreases metastasis, and inhibits response to PPAR ligands.
BMC cancer 20100101
-
Melengestrol acetate enhances adipogenic gene expression in cultured muscle-derived cells.
Journal of animal science 20091201
-
Down-regulation of lipoprotein lipase increases glucose uptake in L6 muscle cells.
Biochemical and biophysical research communications 20091106
-
Activation of peroxisome proliferator-activated receptor-gamma induces apoptosis on acute promyelocytic leukemia cells via downregulation of XIAP.
International journal of molecular medicine 20091101
-
Structurally diverse peroxisome proliferator-activated receptor agonists induce apoptosis in human uro-epithelial cells by a receptor-independent mechanism involving store-operated calcium channels.
Cell proliferation 20091001
-
Peroxisome-proliferator activator receptor-gamma activation decreases attachment of endometrial cells to peritoneal mesothelial cells in an in vitro model of the early endometriotic lesion.
Molecular human reproduction 20091001
-
Hepatitis C virus NS5A protein increases hepatic lipid accumulation via induction of activation and expression of PPARgamma.
FEBS letters 20090903
-
Peroxisome proliferator-activated receptor (PPAR)-gamma positively controls and PPARalpha negatively controls cyclooxygenase-2 expression in rat brain astrocytes through a convergence on PPARbeta/delta via mutual control of PPAR expression levels.
Molecular pharmacology 20090801
-
Activators of PPARs and LXR decrease the adverse effects of exogenous glucocorticoids on the epidermis.
Experimental dermatology 20090701
-
Peroxisome proliferator-activated receptor gamma negatively regulates allergic rhinitis in mice.
Allergology international : official journal of the Japanese Society of Allergology 20090601
-
Peroxisome proliferator-activated receptor-gamma and retinoid X receptor agonists synergistically suppress proliferation of immortalized endometrial stromal cells.
Fertility and sterility 20090501
-
In vitro and in vivo anti-melanoma effects of ciglitazone.
The Journal of investigative dermatology 20090501
-
Peroxisome proliferator-activating receptors: a new way to treat melanoma?
The Journal of investigative dermatology 20090501
-
PPARgamma-independent antitumor effects of thiazolidinediones.
Cancer letters 20090418
-
Peroxisome proliferator-activated receptor {gamma} stimulation of adipocyte ApoE gene transcription mediated by the liver receptor X pathway.
The Journal of biological chemistry 20090417
-
Type 2 deiodinase expression is induced by peroxisomal proliferator-activated receptor-gamma agonists in skeletal myocytes.
Endocrinology 20090401
-
Inhibition of adipocyte differentiation by insulin-like growth factor-binding protein-3.
American journal of physiology. Endocrinology and metabolism 20090401
-
Enhanced effects of PPARgamma ligands and RXR selective retinoids in combination to inhibit migration and invasiveness in cancer cells.
Oncology reports 20090401
-
Autoradiographical imaging of PPARgamma agonist effects on PBR/TSPO binding in TASTPM mice.
Experimental neurology 20090401
-
A proteomic approach to characterizing ciglitazone-induced cancer cell differentiation in Hep-G2 cell line.
Biochimica et biophysica acta 20090401
-
Ciglitazone induces apoptosis via activation of p38 MAPK and AIF nuclear translocation mediated by reactive oxygen species and Ca(2+) in opossum kidney cells.
Toxicology 20090304
-
The thiazolidinedione ciglitazone reduces bacterial outgrowth and early inflammation during Streptococcus pneumoniae pneumonia in mice.
Critical care medicine 20090201
-
TZDs reduce mitochondrial ROS production and enhance mitochondrial biogenesis.
Biochemical and biophysical research communications 20090130
-
Effects of ciglitazone and troglitazone on the proliferation of human stomach cancer cells.
World journal of gastroenterology 20090121
-
Thiazolidinediones regulate expression of cell cycle proteins in human prostate cancer cells via PPARgamma-dependent and PPARgamma-independent pathways.
Cell cycle (Georgetown, Tex.) 20090115
-
Effect of peroxisome proliferator-activated receptor-gamma on airway smooth muscle thickening in a murine model of chronic asthma.
International archives of allergy and immunology 20090101
-
Rosiglitazone prevents high glucose-induced vascular endothelial growth factor and collagen IV expression in cultured mesangial cells.
Experimental diabetes research 20090101
-
Involvement of peroxisome proliferator-activated receptor gamma in gonadal steroidogenesis and steroidogenic acute regulatory protein expression.
Reproduction, fertility, and development 20090101
-
CD36 signaling inhibits the translation of heat shock protein 70 induced by oxidized low density lipoprotein through activation of peroxisome proliferators-activated receptor gamma.
Experimental & molecular medicine 20081231
-
15-deoxy-Delta12,14-prostaglandin J2 inhibits INF-gamma-induced JAK/STAT1 signalling pathway activation and IP-10/CXCL10 expression in mesangial cells.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20081201
-
Molecular characterization of peroxisome proliferator-activated receptors (PPARs) and their gene expression in the differentiating adipocytes of red sea bream Pagrus major.
Comparative biochemistry and physiology. Part B, Biochemistry & molecular biology 20081101
-
Ciglitazone, a PPARgamma agonist, ameliorates diabetic nephropathy in part through homocysteine clearance.
American journal of physiology. Endocrinology and metabolism 20081101
-
Peroxisome proliferator-activated receptor gamma overexpression suppresses growth and induces apoptosis in human multiple myeloma cells.
Clinical cancer research : an official journal of the American Association for Cancer Research 20081015
-
The effect of plasminogen activator inhibitor-1 -675 4G/5G polymorphism on PAI-1 gene expression and adipocyte differentiation.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 20081001
-
Keratinocyte-derived vascular endothelial growth factor biosynthesis represents a pleiotropic side effect of peroxisome proliferator-activated receptor-gamma agonist troglitazone but not rosiglitazone and involves activation of p38 mitogen-activated protein kinase: implications for diabetes-impaired skin repair.
Molecular pharmacology 20081001
-
Troglitazone increases IL-1beta induced cyclooxygenase-2 and inducible nitric oxide synthase expression via enhanced phosphorylation of IkappaBalpha in vascular smooth muscle cells from Wistar-Kyoto rats and spontaneously hypertensive rats.
Biological & pharmaceutical bulletin 20081001
-
Ciglitazone ameliorates lung inflammation by modulating the inhibitor kappaB protein kinase/nuclear factor-kappaB pathway after hemorrhagic shock.
Critical care medicine 20081001
-
Systemic PPARgamma ligation inhibits allergic immune response in the skin.
The Journal of investigative dermatology 20080901
-
Modulation of cell growth and PPARgamma expression in human colorectal cancer cell lines by ciglitazone.
Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie 20080901
-
Molecular mechanism of protection against chemically and gamma-radiation induced apoptosis in human colon cancer cells.
Journal of physiology and pharmacology : an official journal of the Polish Physiological Society 20080801
-
PPAR gamma regulates MITF and beta-catenin expression and promotes a differentiated phenotype in mouse melanoma S91.
Pigment cell & melanoma research 20080601
-
CITED2 signals through peroxisome proliferator-activated receptor-gamma to regulate death of cortical neurons after DNA damage.
The Journal of neuroscience : the official journal of the Society for Neuroscience 20080521
-
Effects of the mango components mangiferin and quercetin and the putative mangiferin metabolite norathyriol on the transactivation of peroxisome proliferator-activated receptor isoforms.
Journal of agricultural and food chemistry 20080514
-
PPAR-gamma agonists inhibit profibrotic phenotypes in human lung fibroblasts and bleomycin-induced pulmonary fibrosis.
American journal of physiology. Lung cellular and molecular physiology 20080501
-
Pharmacological exploitation of the peroxisome proliferator-activated receptor gamma agonist ciglitazone to develop a novel class of androgen receptor-ablative agents.
Journal of medicinal chemistry 20080410
-
Activation of peroxisome proliferator-activated receptor gamma inhibits TNF-alpha-mediated osteoclast differentiation in human peripheral monocytes in part via suppression of monocyte chemoattractant protein-1 expression.
Bone 20080401
-
The synthetic peroxisome proliferator-activated receptor-gamma agonist ciglitazone attenuates neuroinflammation and accelerates encapsulation in bacterial brain abscesses.
Journal of immunology (Baltimore, Md. : 1950) 20080401
-
Ciglitazone induces caspase-independent apoptosis through down-regulation of XIAP and survivin in human glioma cells.
Neurochemical research 20080301
-
Nuclear receptor agonists improve insulin responsiveness in cultured cardiomyocytes through enhanced signaling and preserved cytoskeletal architecture.
Endocrinology 20080301
-
Ciglitazone induces caspase-independent apoptosis via p38-dependent AIF nuclear translocation in renal epithelial cells.
Toxicology 20080203
-
Effects of 15-deoxy-Delta12, 14 prostaglandin J2 and ciglitazone on human cancer cell cycle progression and death: the role of PPARgamma.
European journal of pharmacology 20080202
-
Methacholine-induced pulmonary gas trapping in a mouse model of allergic asthma: effect of inhaled budesonide and ciglitazone.
European journal of pharmacology 20080106
-
PPAR and LXR activators regulate ABCA12 expression in human keratinocytes.
The Journal of investigative dermatology 20080101
-
Ciglitazone, an agonist of peroxisome proliferator-activated receptor gamma, exerts potentiated cytostatic/cytotoxic effects against tumor cells when combined with lovastatin.
International journal of oncology 20080101
-
PPAR gamma agonist normalizes glomerular filtration rate, tissue levels of homocysteine, and attenuates endothelial-myocyte uncoupling in alloxan induced diabetic mice.
International journal of biological sciences 20080101
-
Eicosapentaenoic acid inhibits interleukin-6 production in interleukin-1beta-stimulated C6 glioma cells through peroxisome proliferator-activated receptor-gamma.
Prostaglandins, leukotrienes, and essential fatty acids 20080101
-
Ciglitazone and 15d-PGJ2 induced suicidal erythrocyte death.
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 20080101
-
Expression of STATs and their inhibitors SOCS and PIAS in brain tumors. In vitro and in vivo study.
Neoplasma 20080101
-
[Pathophysiological relevance of peroxisome proliferators activated receptors (PPAR) to joint diseases - the pro and con of agonists].
Journal de la Societe de biologie 20080101
-
Pioglitazone, a ligand for peroxisome proliferator-activated receptor-gamma acts as an inhibitor of colon cancer liver metastasis.
Anticancer research 20080101
-
Anti-inflammatory lipid mediator 15d-PGJ2 inhibits translation through inactivation of eIF4A.
The EMBO journal 20071212
-
Peroxisome proliferator-activated receptor gamma is required for the inhibitory effect of ciglitazone but not 15-deoxy-Delta 12,14-prostaglandin J2 on the NFkappaB pathway in human endothelial cells.
Shock (Augusta, Ga.) 20071201
-
Inactivation of peroxisome proliferator-activated receptor isoforms alpha, beta/delta, and gamma mediate distinct facets of hypertrophic transformation of adult cardiac myocytes.
Pflugers Archiv : European journal of physiology 20071201
-
Minor polar compounds extra-virgin olive oil extract (MPC-OOE) inhibits NF-kappa B translocation in human monocyte/macrophages.
Pharmacological research 20071201
-
Transcriptional upregulation of gastrin in response to peroxisome proliferator-activated receptor gamma agonist triggers cell survival pathways.
Journal of physiology and pharmacology : an official journal of the Polish Physiological Society 20071201
-
Diverse cardioprotective signaling mechanisms of peroxisome proliferator-activated receptor-gamma ligands, 15-deoxy-Delta12,14-prostaglandin J2 and ciglitazone, in reperfusion injury: role of nuclear factor-kappaB, heat shock factor 1, and Akt.
Shock (Augusta, Ga.) 20071101
-
Synergistic effects of RXR alpha and PPAR gamma ligands to inhibit growth in human colon cancer cells--phosphorylated RXR alpha is a critical target for colon cancer management.
Gut 20071101
-
Capacitative calcium entry contributes to the differential transactivation of the epidermal growth factor receptor in response to thiazolidinediones.
Molecular pharmacology 20071101
-
Growth inhibition and apoptosis induced in human leiomyoma cells by treatment with the PPAR gamma ligand ciglitizone.
Molecular human reproduction 20071101
-
Peroxisome proliferator-activated receptor agonists as potential therapeutic agents in multiple sclerosis.
Mini reviews in medicinal chemistry 20071101
-
[Molecular mechanism of ciglitazone inhibiting the expression of extracellular matrix in human hepatic stellate cells].
Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology 20071101
-
Comparison of vascular relaxation, lipolysis and glucose uptake by peroxisome proliferator-activated receptor-gamma activation in +db/+m and +db/+db mice.
European journal of pharmacology 20071015
-
Mechanism of TNFalpha-induced IL-1alpha, IL-1beta and IL-6 expression in human cardiac fibroblasts: effects of statins and thiazolidinediones.
Cardiovascular research 20071001
-
Delta5 desaturase mRNA levels are increased by simvastatin via SREBP-1 at early stages, not via PPARalpha, in THP-1 cells.
European journal of pharmacology 20071001
-
Investigation of the lipophilic behaviour of some thiazolidinediones. Relationships with PPAR-gamma activity.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20071001
-
PPARgamma inhibits osteogenesis via the down-regulation of the expression of COX-2 and iNOS in rats.
Bone 20071001
-
Cytotoxicity of peroxisome proliferator-activated receptor alpha and gamma agonists in renal proximal tubular cell lines.
Toxicology in vitro : an international journal published in association with BIBRA 20070901
-
Apoptotic action of peroxisome proliferator-activated receptor-gamma activation in human non small-cell lung cancer is mediated via proline oxidase-induced reactive oxygen species formation.
Molecular pharmacology 20070901
-
Quantification of PPAR-gamma protein in monocyte/macrophages from healthy smokers and non-smokers: a possible direct effect of nicotine.
Life sciences 20070823
-
Inhibitory effect of meloxicam, a selective cyclooxygenase-2 inhibitor, and ciglitazone, a peroxisome proliferator-activated receptor gamma ligand, on the growth of human ovarian cancers.
Cancer 20070815
-
Adipocyte fatty acid-binding protein (aP2), a newly identified LXR target gene, is induced by LXR agonists in human THP-1 cells.
Molecular and cellular biochemistry 20070801
-
Ciglitazone, a peroxisome proliferator-activated receptor gamma inducer, ameliorates renal preglomerular production and activity of angiotensin II and thromboxane A2 in glycerol-induced acute renal failure.
The Journal of pharmacology and experimental therapeutics 20070801
-
Glitazones induce astroglioma cell death by releasing reactive oxygen species from mitochondria: modulation of cytotoxicity by nitric oxide.
Molecular pharmacology 20070801
-
Interaction of ligands for the peroxisome proliferator-activated receptor gamma with the endocannabinoid system.
British journal of pharmacology 20070801
-
Mitochondria, ciglitazone and liver: a neglected interaction in biochemical pharmacology.
European journal of pharmacology 20070712
-
Pro-MMP-2 activation by the PPARgamma agonist, ciglitazone, induces cell invasion through the generation of ROS and the activation of ERK.
FEBS letters 20070710
-
Ciglitazone mediates COX-2 dependent suppression of PGE2 in human non-small cell lung cancer cells.
Prostaglandins, leukotrienes, and essential fatty acids 20070701
-
Mechanism of thiazolidinedione-dependent cell death in Jurkat T cells.
Molecular pharmacology 20070601
-
A role for inflammatory mediators in the IL-18 mediated attenuation of LTP in the rat dentate gyrus.
Neuropharmacology 20070601
-
Does the inhibition of c-myc expression mediate the anti-tumor activity of PPAR's ligands in prostate cancer cell lines?
Archives of biochemistry and biophysics 20070601
-
Peroxisome proliferator-activated receptor gamma activation relieves expression of behavioral sensitization to methamphetamine in mice.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20070501
-
Transdifferentiation of porcine satellite cells to adipoblasts with ciglitizone.
Journal of animal science 20070501
-
Thiazolidinedione drugs down-regulate CXCR4 expression on human colorectal cancer cells in a peroxisome proliferator activated receptor gamma-dependent manner.
International journal of oncology 20070501
-
A peroxisome-proliferator activated receptor-gamma ligand could regulate the expression of leptin receptor on human hepatic stellate cells.
Histochemistry and cell biology 20070501
-
Peroxisome proliferator-activated receptor-gamma agonists inhibit respiratory syncytial virus-induced expression of intercellular adhesion molecule-1 in human lung epithelial cells.
Immunology 20070501
-
Glycogen synthase 2 is a novel target gene of peroxisome proliferator-activated receptors.
Cellular and molecular life sciences : CMLS 20070501
-
Thiazolidinedione ameliorates renal injury in experimental diabetic rats through anti-inflammatory effects mediated by inhibition of NF-kappaB activation.
American journal of physiology. Renal physiology 20070401
-
Peroxisome proliferator-activated receptor gamma (PPARgamma) and immunoregulation: enhancement of regulatory T cells through PPARgamma-dependent and -independent mechanisms.
Journal of immunology (Baltimore, Md. : 1950) 20070401
-
Peroxisome proliferator-activated receptor gamma and retinoic acid receptor synergistically up-regulate the tumor suppressor PTEN in human promyeloid leukemia cells.
International journal of hematology 20070401
-
Troglitazone inhibits oxidized low-density lipoprotein-induced macrophage proliferation: impact of the suppression of nuclear translocation of ERK1/2.
Atherosclerosis 20070301
-
PPAR-gamma agonist, ciglitazone, increases pigmentation and migration of human melanocytes.
Experimental dermatology 20070201
-
Effect of thiazolidinediones on bile acid transport in rat liver.
Life sciences 20070130
-
PPAR agonists modulate human osteoclast formation and activity in vitro.
Bone 20070101
-
Peroxisome proliferator-activated receptor gamma (PPARgamma) regulates trefoil factor family 2 (TFF2) expression in gastric epithelial cells.
The international journal of biochemistry & cell biology 20070101
-
Upregulation of MIP-2 (CXCL2) expression by 15-deoxy-Delta(12,14)-prostaglandin J(2) in mouse peritoneal macrophages.
Immunology and cell biology 20070101
-
Potential role for peroxisome proliferator-activated receptor gamma in regulating luteal lifespan in the rat.
Reproduction (Cambridge, England) 20070101
-
Peroxisome proliferator-activated receptor-gamma agonists cause growth arrest and apoptosis in human ovarian carcinoma cell lines.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20070101
-
Activation of peroxisome proliferator-activated receptor-gamma protects pancreatic beta-cells from cytokine-induced cytotoxicity via NF kappaB pathway.
The international journal of biochemistry & cell biology 20070101
-
Reversal of systemic hypertension-associated cardiac remodeling in chronic pressure overload myocardium by ciglitazone.
International journal of biological sciences 20070101
-
Ciglitazone ameliorates homocysteine-mediated mitochondrial translocation and matrix metalloproteinase-9 activation in endothelial cells by inducing peroxisome proliferator activated receptor-gamma activity.
Cellular and molecular biology (Noisy-le-Grand, France) 20061231
-
15-deoxy-Delta12,14-prostaglandin J2 (15d-PGJ2) and ciglitazone modulate Staphylococcus aureus-dependent astrocyte activation primarily through a PPAR-gamma-independent pathway.
Journal of neurochemistry 20061201
-
Does the PGC-1/PPARgamma pathway play a role in Com-1/p8 mediated cell growth inhibition in prostate cancer?
International journal of molecular medicine 20061201
-
The peroxisome proliferator-activated receptor gamma (PPARgamma) ligands 15-deoxy-Delta12,14-prostaglandin J2 and ciglitazone induce human B lymphocyte and B cell lymphoma apoptosis by PPARgamma-independent mechanisms.
Journal of immunology (Baltimore, Md. : 1950) 20061015
-
Type II nuclear hormone receptors, coactivator, and target gene repression in adipose tissue in the acute-phase response.
Journal of lipid research 20061001
-
Cellular and molecular consequences of peroxisome proliferator-activated receptor-gamma activation in ovarian cancer cells.
Neoplasia (New York, N.Y.) 20061001
-
Activation of peroxisome proliferator-activated receptor-gamma (PPARgamma) induces cell death through MAPK-dependent mechanism in osteoblastic cells.
Toxicology and applied pharmacology 20060901
-
Peroxisomal proliferator-activated receptor-gamma agonists induce partial reversion of epithelial-mesenchymal transition in anaplastic thyroid cancer cells.
Endocrinology 20060901
-
Role of PPAR-gamma on the pathogenesis and vascular changes in glycerol-induced acute renal failure.
Pharmacological research 20060901
-
PPARgamma antagonists reverse the inhibition of neural antigen-specific Th1 response and experimental allergic encephalomyelitis by Ciglitazone and 15-deoxy-Delta12,14-prostaglandin J2.
Journal of neuroimmunology 20060901
-
Rosiglitazone ameliorates cisplatin-induced renal injury in mice.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20060801
-
Troglitazone acutely inhibits protein synthesis in endothelial cells via a novel mechanism involving protein phosphatase 2A-dependent p70 S6 kinase inhibition.
American journal of physiology. Cell physiology 20060801
-
TGF-beta inhibition of CTL re-stimulation requires accessory cells and induces peroxisome-proliferator-activated receptor-gamma (PPAR-gamma).
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20060801
-
Differences in hepatotoxicity and gene expression profiles by anti-diabetic PPAR gamma agonists on rat primary hepatocytes and human HepG2 cells.
Molecular diversity 20060801
-
Peroxisome proliferator-activated receptor-gamma agonists inhibit the replication of respiratory syncytial virus (RSV) in human lung epithelial cells.
Virology 20060705
-
Interleukin-2 suppression by 2-arachidonyl glycerol is mediated through peroxisome proliferator-activated receptor gamma independently of cannabinoid receptors 1 and 2.
Molecular pharmacology 20060701
-
Effects of PPARgamma agonists on cell survival and focal adhesions in a Chinese thyroid carcinoma cell line.
Journal of cellular biochemistry 20060701
-
Mono(2-ethylhexyl)phthalate and mono-n-butyl phthalate activation of peroxisome proliferator activated-receptors alpha and gamma in breast.
Toxicology letters 20060601
-
Thiazolidinediones and rexinoids induce peroxisome proliferator-activated receptor-coactivator (PGC)-1alpha gene transcription: an autoregulatory loop controls PGC-1alpha expression in adipocytes via peroxisome proliferator-activated receptor-gamma coactivation.
Endocrinology 20060601
-
PPAR-gamma ligands and amino acid deprivation promote apoptosis of melanoma, prostate, and breast cancer cells.
Cancer letters 20060508
-
Peroxisome proliferator-activated receptor gamma-independent repression of prostate-specific antigen expression by thiazolidinediones in prostate cancer cells.
Molecular pharmacology 20060501
-
A comparison of thiazolidinedione-induced adipogenesis and myogenesis in stromal-vascular cells from subcutaneous adipose tissue or semitendinosus muscle of postnatal pigs.
Journal of animal science 20060501
-
Differential modulation of cell cycle, apoptosis and PPARgamma2 gene expression by PPARgamma agonists ciglitazone and 9-hydroxyoctadecadienoic acid in monocytic cells.
Prostaglandins, leukotrienes, and essential fatty acids 20060501
-
Peroxisome proliferator-activated receptors-gamma activator, ciglitazone, inhibits human melanocyte growth through induction of apoptosis.
Archives of dermatological research 20060401
-
Bioassay for the identification of natural product-based activators of peroxisome proliferator-activated receptor-gamma (PPARgamma): the marine sponge metabolite psammaplin A activates PPARgamma and induces apoptosis in human breast tumor cells.
Journal of natural products 20060401
-
Identification and treatment of aggressive thyroid cancers. Part 2: risk assessment and treatment.
Oncology (Williston Park, N.Y.) 20060401
-
[Effects of peroxisome proliferators-activated receptor gamma agonists on transforming growth factor-beta1 and Smads signal pathway: experiment with rat renal fibroblasts].
Zhonghua yi xue za zhi 20060321
-
Peroxisome-proliferator-activated receptor-gamma agonists inhibit the release of proinflammatory cytokines from RSV-infected epithelial cells.
Virology 20060315
-
Activation of peroxisome proliferator-activated receptor-gamma decreases pancreatic cancer cell invasion through modulation of the plasminogen activator system.
Molecular cancer research : MCR 20060301
-
Adaptive-outward and maladaptive-inward arterial remodeling measured by intravascular ultrasound in hyperhomocysteinemia and diabetes.
Journal of cardiovascular pharmacology and therapeutics 20060301
-
Niacin induces PPARgamma expression and transcriptional activation in macrophages via HM74 and HM74a-mediated induction of prostaglandin synthesis pathways.
Biochemical pharmacology 20060227
-
The PPARgamma ligand, rosiglitazone, reduces airways hyperresponsiveness in a murine model of allergen-induced inflammation.
Pulmonary pharmacology & therapeutics 20060101
-
CDK5 is a novel regulatory protein in PPARgamma ligand-induced antiproliferation.
International journal of oncology 20060101
-
Involvement of PPARgamma in oxidative stress-mediated prostaglandin E(2) production in SZ95 human sebaceous gland cells.
The Journal of investigative dermatology 20060101
-
Thiazolidinediones inhibit albumin uptake by proximal tubular cells through a mechanism independent of peroxisome proliferator activated receptor gamma.
American journal of nephrology 20060101
-
Influence of ciglitazone on A549 cells growth in vitro and in vivo and mechanism.
Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban 20060101
-
Peroxisome proliferator-activated receptor-gamma is expressed by rat peritoneal mesothelial cells: its potential role in peritoneal cavity local defense.
American journal of nephrology 20060101
-
Ciglitazone-induced p27 gene transcriptional activity is mediated through Sp1 and is negatively regulated by the MAPK signaling pathway.
Cellular signalling 20051201
-
LXR and PPAR activators stimulate cholesterol sulfotransferase type 2 isoform 1b in human keratinocytes.
Journal of lipid research 20051201
-
Effect of peroxisome proliferator-activated receptor-gamma ligands on the expression of retinoic acid-inducible gene-I in endothelial cells stimulated with lipopolysaccharide.
Prostaglandins & other lipid mediators 20051201
-
Effect of peroxisome proliferator-activated receptor-gamma ligand on inflammation of human gallbladder epithelial cells.
World journal of gastroenterology 20051014
-
Ciglitazone inhibits the antigen-induced leukotrienes production independently of PPARgamma in RBL-2H3 mast cells.
European journal of pharmacology 20051003
-
Inhibition of adult liver progenitor (oval) cell growth and viability by an agonist of the peroxisome proliferator activated receptor (PPAR) family member gamma, but not alpha or delta.
Carcinogenesis 20051001
-
Inhibitors of prostaglandin transport and metabolism augment protease-activated receptor-2-mediated increases in prostaglandin E2 levels and smooth muscle relaxation in mouse isolated trachea.
The Journal of pharmacology and experimental therapeutics 20050901
-
Peroxisome proliferator-activated receptor gamma ligands stimulate endothelial nitric oxide production through distinct peroxisome proliferator-activated receptor gamma-dependent mechanisms.
Arteriosclerosis, thrombosis, and vascular biology 20050901
-
Peroxisome proliferator activated receptor-gamma (PPARgamma) represses thyroid hormone signaling in growth plate chondrocytes.
Bone 20050901
-
Ciglitazone-induced cellular anti-proliferation increases p27kip1 protein levels through both increased transcriptional activity and inhibition of proteasome degradation.
Cellular signalling 20050701
-
A novel PPAR response element in the murine iNOS promoter.
Molecular immunology 20050701
-
Homocysteine-dependent cardiac remodeling and endothelial-myocyte coupling in a 2 kidney, 1 clip Goldblatt hypertension mouse model.
Canadian journal of physiology and pharmacology 20050701
-
15-Deoxy-delta12,14-PGJ2 inhibits IL-6-induced Stat3 phosphorylation in lymphocytes.
Experimental & molecular medicine 20050630
-
PPARgamma agonists inhibit TGF-beta induced pulmonary myofibroblast differentiation and collagen production: implications for therapy of lung fibrosis.
American journal of physiology. Lung cellular and molecular physiology 20050601
-
Upregulation of LPS-induced chemokine KC expression by 15-deoxy-delta12,14-prostaglandin J2 in mouse peritoneal macrophages.
Immunology and cell biology 20050601
-
Oleoylethanolamide, an endogenous PPAR-alpha agonist, lowers body weight and hyperlipidemia in obese rats.
Neuropharmacology 20050601
-
Inhibitors of the arachidonic acid pathway and peroxisome proliferator-activated receptor ligands have superadditive effects on lung cancer growth inhibition.
Cancer research 20050515
-
Selective activation of PPARgamma in breast, colon, and lung cancer cell lines.
Molecular and cellular endocrinology 20050512
-
Mechanism of the anti-inflammatory effect of thiazolidinediones: relationship with the glucocorticoid pathway.
Molecular pharmacology 20050501
-
Peroxisome proliferator-activated receptor-gamma ligands regulate endothelial membrane superoxide production.
American journal of physiology. Cell physiology 20050401
-
Peroxisome proliferator-activated receptor gamma-independent ablation of cyclin D1 by thiazolidinediones and their derivatives in breast cancer cells.
Molecular pharmacology 20050401
-
Peroxisome proliferator-activated receptor gamma-independent activation of p38 MAPK by thiazolidinediones involves calcium/calmodulin-dependent protein kinase II and protein kinase R: correlation with endoplasmic reticulum stress.
The Journal of biological chemistry 20050318
-
PPAR-gamma ligands up-regulate basic fibroblast growth factor-induced VEGF release through amplifying SAPK/JNK activation in osteoblasts.
Biochemical and biophysical research communications 20050304
-
Ciglitazone-induced lenticular opacities in rats: in vivo and whole lens explant culture evaluation.
The Journal of pharmacology and experimental therapeutics 20050301
-
Ciglitazone induces early cellular proliferation and NF-kappaB transcriptional activity in colon cancer cells through p65 phosphorylation.
The international journal of biochemistry & cell biology 20050301
-
Ciglitazone increases basal cytokine expression in the central nervous system of adult rats.
Brain research 20050209
-
Ciglitizone inhibits cell proliferation in human uterine leiomyoma via activation of store-operated Ca2+ channels.
American journal of physiology. Cell physiology 20050201
-
Epidermal peroxisome proliferator-activated receptor gamma as a target for ultraviolet B radiation.
The Journal of biological chemistry 20050107
-
Influence of physiological conditions on laser damage thresholds for blood, heart, and liver cells.
Lasers in surgery and medicine 20050101
-
Peroxisome proliferator-activated receptors (PPAR) agonists affect cell viability, apoptosis and expression of cell cycle related proteins in cell lines of glial brain tumors.
Neoplasma 20050101
-
A two-dimensional electrophoresis preliminary approach to human hepatocarcinoma differentiation induced by PPAR-agonists.
Journal of cellular and molecular medicine 20050101
-
Gene expression profiling of potential peroxisome proliferator-activated receptor (PPAR) target genes in human hepatoblastoma cell lines inducibly expressing different PPAR isoforms.
Nuclear receptor 20050101
-
Ox-LDL suppresses PMA-induced MMP-9 expression and activity through CD36-mediated activation of PPAR-g.
Experimental & molecular medicine 20041231
-
Nuclear receptor activation and interaction with morphine.
Journal of neuroimmunology 20041201
-
Peroxisome proliferator-activated receptor-gamma and its ligands attenuate biologic functions of human natural killer cells.
Blood 20041115
-
Divergent effects of peroxisome proliferator-activated receptor gamma agonists and tumor necrosis factor alpha on adipocyte ApoE expression.
The Journal of biological chemistry 20041112
-
Human multiple myeloma cells express peroxisome proliferator-activated receptor gamma and undergo apoptosis upon exposure to PPARgamma ligands.
Clinical immunology (Orlando, Fla.) 20041101
-
Regulation of cellular processes by PPARgamma ligands in neuroblastoma cells is modulated by the level of retinoblastoma protein expression.
Biochemical Society transactions 20041101
-
Peroxisome proliferator-activated receptor-gamma induces regression of endometrial explants in a rat model of endometriosis.
Fertility and sterility 20041001
-
Implication of peroxisome proliferator-activated receptor gamma and proinflammatory cytokines in gastric carcinogenesis: link to Helicobacter pylori-infection.
Journal of pharmacological sciences 20041001
-
Peroxisome proliferator-activated receptor gamma ligands, 15-deoxy-Delta12,14-prostaglandin J2, and ciglitazone, induce growth inhibition and cell cycle arrest in hepatic oval cells.
Biochemical and biophysical research communications 20040917
-
Ciglitizone and 15d PGJ2 induce apoptosis in Jurkat and Raji cells.
International immunopharmacology 20040901
-
[A study on inflammatory regulation of human gallbladder epithelial cells by PPAR-gamma ligand].
Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition 20040901
-
Ciglitazone inhibits oxidized-low density lipoprotein induced immune maturation of dendritic cells.
Journal of cardiovascular pharmacology 20040901
-
[Ciglitazone inhibits growth of lung cancer cells A549 in vitro and in vivo: an experimental study].
Zhonghua zhong liu za zhi [Chinese journal of oncology] 20040901
-
Peroxisome-proliferator-activated receptor (PPAR)-gamma activation stimulates keratinocyte differentiation.
The Journal of investigative dermatology 20040801
-
Activation of NFkappaB represents the central event in the neoplastic progression associated with Barrett's esophagus: a possible link to the inflammation and overexpression of COX-2, PPARgamma and growth factors.
Digestive diseases and sciences 20040801
-
Mitochondrial respiratory chain dysfunction, a non-receptor-mediated effect of synthetic PPAR-ligands: biochemical and pharmacological implications.
Biochemical and biophysical research communications 20040702
-
Growth hormone inhibits apoptosis in human colonic cancer cell lines: antagonistic effects of peroxisome proliferator activated receptor-gamma ligands.
Endocrinology 20040701
-
Dissociation of oxidant production by peroxisome proliferator-activated receptor ligands from cell death in human cell lines.
Free radical biology & medicine 20040701
-
15-deoxy-Delta12,14-prostaglandin J2 inhibits glucocorticoid binding and signaling in macrophages through a peroxisome proliferator-activated receptor gamma-independent process.
Journal of immunology (Baltimore, Md. : 1950) 20040615
-
PPARgamma agonists ameliorate endothelial cell activation via inhibition of diacylglycerol-protein kinase C signaling pathway: role of diacylglycerol kinase.
Circulation research 20040611
-
The synthetic ligand of peroxisome proliferator-activated receptor-gamma ciglitazone affects human glioblastoma cell lines.
The Journal of pharmacology and experimental therapeutics 20040601
-
Differential effects of peroxisome proliferator activated receptor-gamma (PPAR gamma) ligands in proximal tubular cells: thiazolidinediones are partial PPAR gamma agonists.
Kidney international 20040601
-
PPARgamma inhibits GH synthesis and secretion and increases apoptosis of pituitary GH-secreting adenomas.
European journal of endocrinology 20040601
-
15-deoxy-delta12,14-prostaglandin J2 inhibits Bay 11-7085-induced sustained extracellular signal-regulated kinase phosphorylation and apoptosis in human articular chondrocytes and synovial fibroblasts.
The Journal of biological chemistry 20040521
-
15-deoxy-delta 12,14-prostaglandin J2 induces heme oxygenase-1 gene expression in a reactive oxygen species-dependent manner in human lymphocytes.
The Journal of biological chemistry 20040521
-
Structure-activity requirements for the antiproliferative effect of troglitazone derivatives mediated by depletion of intracellular calcium.
Bioorganic & medicinal chemistry letters 20040517
-
Peroxisome proliferator-activated receptor gamma is expressed in airways and inhibits features of airway remodeling in a mouse asthma model.
The Journal of allergy and clinical immunology 20040501
-
Ligands of peroxisome proliferator-activated receptor gamma inhibit lung cancer cell growth and induce apoptosis by stimulation of P21 expression.
Chest 20040501
-
Peroxisome proliferator ameliorates endocardial endothelial and muscarinic dysfunction in spontaneously hypertensive rats.
Antioxidants & redox signaling 20040401
-
Direct attenuation of plasminogen activator inhibitor type-1 expression in human adipose tissue by thiazolidinediones.
Thrombosis and haemostasis 20040401
-
Proteome analysis of adipogenesis.
Proteomics 20040401
-
Up-regulation of p21 gene expression by peroxisome proliferator-activated receptor gamma in human lung carcinoma cells.
Clinical cancer research : an official journal of the American Association for Cancer Research 20040315
-
Anti-inflammatory and antiproliferative actions of PPAR-gamma agonists on T lymphocytes derived from MS patients.
Journal of leukocyte biology 20040301
-
Effect of peroxisome proliferator activated receptor gamma ligands on growth and gene expression profiles of gastric cancer cells.
Gut 20040301
-
[The effects of nuclear factor kappa B decoy oligodeoxynucleotides on ciglitazone-induced differentiation of lung cancer cells A549].
Zhonghua nei ke za zhi 20040301
-
Src kinase-dependent epidermal growth factor receptor transactivation in PPARgamma ligand-induced suppression of Porphyromonas gingivalis interference with salivary mucin synthesis.
IUBMB life 20040301
-
PPARalpha activators inhibit vascular endothelial growth factor receptor-2 expression by repressing Sp1-dependent DNA binding and transactivation.
Circulation research 20040220
-
Interferon regulatory factor-1 mediates PPARgamma-induced apoptosis in vascular smooth muscle cells.
Arteriosclerosis, thrombosis, and vascular biology 20040201
-
15-Deoxy-delta(12,14)-prostaglandin J2 inhibits the IL-1beta-induced expression of granulocyte-macrophage colony-stimulating factor in BEAS-2B bronchial epithelial cells.
The Tohoku journal of experimental medicine 20040201
-
Sensing environmental lipids by dendritic cell modulates its function.
Journal of immunology (Baltimore, Md. : 1950) 20040101
-
Activation of peroxisome proliferator-activated receptor-gamma in dendritic cells inhibits the development of eosinophilic airway inflammation in a mouse model of asthma.
The American journal of pathology 20040101
-
Role of epidermal growth factor receptor transactivation in PPAR gamma-dependent suppression of Helicobacter pylori interference with gastric mucin synthesis.
Inflammopharmacology 20040101
-
Peroxisome proliferator activator receptor-gamma ligands, 15-deoxy-Delta(12,14)-prostaglandin J2 and ciglitazone, reduce systemic inflammation in polymicrobial sepsis by modulation of signal transduction pathways.
Journal of immunology (Baltimore, Md. : 1950) 20031215
-
Peroxisome proliferator-activated receptor agonists inhibit interleukin-1beta-mediated nitric oxide production in cultured lacrimal gland acinar cells.
Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20031201
-
15-deoxy-delta12,14-prostaglandin J2 regulates the functional state and the survival of microglial cells through multiple molecular mechanisms.
Journal of neurochemistry 20031101
-
Inhibition of interleukin-4 production in CD4+ T cells by peroxisome proliferator-activated receptor-gamma (PPAR-gamma) ligands: involvement of physical association between PPAR-gamma and the nuclear factor of activated T cells transcription factor.
Molecular pharmacology 20031101
-
Phosphorylation of PPARgamma via active ERK1/2 leads to its physical association with p65 and inhibition of NF-kappabeta.
Journal of cellular biochemistry 20031101
-
Comparative studies of resistin expression and phylogenomics in human and mouse.
Biochemical and biophysical research communications 20031024
-
Peroxisome proliferator-activated receptor gamma ligands attenuate immunological symptoms of experimental allergic asthma.
Archives of biochemistry and biophysics 20031015
-
The effect of PPARgamma ligands on the proliferation and apoptosis of human melanoma cells.
Melanoma research 20031001
-
Inhibition of IgE-production by peroxisome proliferator-activated receptor ligands.
The Journal of investigative dermatology 20031001
-
Homocysteine mediated expression and secretion of monocyte chemoattractant protein-1 and interleukin-8 in human monocytes.
Circulation research 20030822
-
Inverse relationship between the expression of messenger ribonucleic acid for peroxisome proliferator-activated receptor gamma and P450 side chain cleavage in the rat ovary.
Biology of reproduction 20030801
-
Inhibition of IFN-gamma-mediated inducible nitric oxide synthase induction by the peroxisome proliferator-activated receptor gamma agonist, 15-deoxy-delta 12,14-prostaglandin J2, involves inhibition of the upstream Janus kinase/STAT1 signaling pathway.
Journal of immunology (Baltimore, Md. : 1950) 20030715
-
[Apoptosis of human lung cancer cells induced by activated peroxisome proliferator-activated receptor-gamma and its mechanism].
Zhonghua yi xue za zhi 20030710
-
PPARgamma ligand attenuates PDGF-induced mesangial cell proliferation: role of MAP kinase.
Kidney international 20030701
-
Regulation of retinoic acid receptor beta expression by peroxisome proliferator-activated receptor gamma ligands in cancer cells.
Cancer research 20030701
-
15-Deoxy-delta 12,14-prostaglandin J2 inhibits the expression of granulocyte-macrophage colony-stimulating factor in endothelial cells stimulated with lipopolysaccharide.
Prostaglandins & other lipid mediators 20030701
-
[Effects of peroxisome proliferator-activated receptor-gamma agonist on Fas-mediated apoptosis in HT-29 cells].
The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 20030701
-
Peroxisome proliferator-activated receptor-gamma upregulates caveolin-1 and caveolin-2 expression in human carcinoma cells.
Oncogene 20030619
-
Effects of peroxisome proliferator-activated receptor gamma ligands ciglitazone and 15-deoxy-delta 12,14-prostaglandin J2 on rat cultured cerebellar granule neuronal viability.
Journal of neuroscience research 20030615
-
Inhibition of cyclooxygenase-2 and activation of peroxisome proliferator-activated receptor-gamma synergistically induces apoptosis and inhibits growth of human breast cancer cells.
International journal of molecular medicine 20030601
-
Increased expression of the lipocalin 24p3 as an apoptotic mechanism for MK886.
The Biochemical journal 20030515
-
Activation-induced PPARgamma expression sensitizes primary human T cells toward apoptosis.
Journal of leukocyte biology 20030501
-
Inhibition of proliferation and estrogen receptor signaling by peroxisome proliferator-activated receptor gamma ligands in uterine leiomyoma.
Cancer research 20030315
-
15-Deoxy-Delta(12,14)-prostaglandin J2 inhibits the expression of proinflammatory genes in human blood monocytes via a PPAR-gamma-independent mechanism.
Biochemical and biophysical research communications 20030307
-
Activation of peroxisome proliferator-activated receptors in human airway smooth muscle cells has a superior anti-inflammatory profile to corticosteroids: relevance for chronic obstructive pulmonary disease therapy.
Journal of immunology (Baltimore, Md. : 1950) 20030301
-
Peroxisome proliferator-activated receptor gamma agonists induce proteasome-dependent degradation of cyclin D1 and estrogen receptor alpha in MCF-7 breast cancer cells.
Cancer research 20030301
-
Cytokine regulation by peroxisome proliferator-activated receptor gamma in human endometrial cells.
Fertility and sterility 20030301
-
The antiproliferative effects of PPARgamma ligands in normal human mammary epithelial cells.
Breast cancer research and treatment 20030301
-
The genomic organization of mouse resistin reveals major differences from the human resistin: functional implications.
Gene 20030213
-
Cyclooxygenase-2 expression by nonsteroidal anti-inflammatory drugs in human airway smooth muscle cells: role of peroxisome proliferator-activated receptors.
Journal of immunology (Baltimore, Md. : 1950) 20030115
-
Peroxisome proliferator-activated receptor gamma ligands increase release of nitric oxide from endothelial cells.
Arteriosclerosis, thrombosis, and vascular biology 20030101
-
Thiazolidinediones, a class of anti-diabetic drugs, inhibit Id2 expression through a PPARgamma-independent pathway in human aortic smooth muscle cells.
Cellular and molecular life sciences : CMLS 20030101
-
Thiazolidinedione inhibition of peritoneal inflammation.
Gynecologic and obstetric investigation 20030101
-
Negative growth effects of ciglitazone on kidney interstitial fibroblasts: role of PPAR-gamma.
Kidney & blood pressure research 20030101
-
Agonists of peroxisome-proliferator activated receptor-gamma reduce renal ischemia/reperfusion injury.
American journal of nephrology 20030101
-
Peroxisome proliferator-activated receptor gamma-mediated NF-kappa B activation and apoptosis in pre-B cells.
Journal of immunology (Baltimore, Md. : 1950) 20021215
-
Inhibition of NAD+-dependent 15-hydroxyprostaglandin dehydrogenase (15-PGDH) by cyclooxygenase inhibitors and chemopreventive agents.
Prostaglandins, leukotrienes, and essential fatty acids 20021201
-
Peroxisome proliferator-activated receptor-gamma is a target of nonsteroidal anti-inflammatory drugs mediating cyclooxygenase-independent inhibition of lung cancer cell growth.
Molecular pharmacology 20021101
-
Leptin induces endothelial cell migration through Akt, which is inhibited by PPARgamma-ligands.
Hypertension (Dallas, Tex. : 1979) 20021101
-
[Discovery and development of a new insulin sensitizing agent, pioglitazone].
Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 20021101
-
Glitazones regulate glutamine metabolism by inducing a cellular acidosis in MDCK cells.
American journal of physiology. Endocrinology and metabolism 20021001
-
Studies on non-thiazolidinedione antidiabetic agents. 1. Discovery of novel oxyiminoacetic acid derivatives.
Chemical & pharmaceutical bulletin 20021001
-
Characterization of sucrose-induced changes in cardiac phenotype.
Pflugers Archiv : European journal of physiology 20021001
-
Peroxisome proliferator-activated receptor ligands negatively regulate the expression of the high-affinity IgE receptor Fc epsilon RI in human basophilic KU812 cells.
Biochemical and biophysical research communications 20020920
-
Thiazolidinediones as a novel class of NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase inhibitors.
Archives of biochemistry and biophysics 20020915
-
Stimulation of peroxisome proliferator-activated receptors alpha and gamma blocks HIV-1 replication and TNFalpha production in acutely infected primary blood cells, chronically infected U1 cells, and alveolar macrophages from HIV-infected subjects.
Journal of acquired immune deficiency syndromes (1999) 20020901
-
Thiazolidinedione activation of peroxisome proliferator-activated receptor gamma can enhance mitochondrial potential and promote cell survival.
The Journal of biological chemistry 20020830
-
MAP kinase cascades are activated in astrocytes and preadipocytes by 15-deoxy-Delta(12-14)-prostaglandin J(2) and the thiazolidinedione ciglitazone through peroxisome proliferator activator receptor gamma-independent mechanisms involving reactive oxygenated species.
The Journal of biological chemistry 20020816
-
Ciglitazone inhibits plasmin-induced proinflammatory monocyte activation via modulation of p38 MAP kinase activity.
Thrombosis and haemostasis 20020801
-
Superoxide anion-dependent Raf/MEK/ERK activation by peroxisome proliferator activated receptor gamma agonists 15-deoxy-delta(12,14)-prostaglandin J(2), ciglitazone, and GW1929.
Experimental cell research 20020715
-
Inhibitory effect of peroxisome proliferator-activated receptor-gamma ligands on the expression of IgE heavy chain germline transcripts in the human B cell line DND39.
Biochemical and biophysical research communications 20020712
-
Ligands of the peroxisome proliferator-activated receptors (PPAR-gamma and PPAR-alpha) reduce myocardial infarct size.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 20020701
-
Effects of peroxisome proliferator-activated receptor agonists on LPS-induced neuronal death in mixed cortical neurons: associated with iNOS and COX-2.
Brain research 20020621
-
Induction of apoptosis in human and rat glioma by agonists of the nuclear receptor PPARgamma.
Journal of neurochemistry 20020601
-
Suppression of gastric mucosal inflammatory responses to Helicobacter pylori lipopolysaccharide by peroxisome proliferator-activated receptor gamma activation.
IUBMB life 20020601
-
PPAR activators inhibit endothelial cell migration by targeting Akt.
Biochemical and biophysical research communications 20020524
-
Peroxisome proliferator-activated receptor gamma agonists inhibit HIV-1 replication in macrophages by transcriptional and post-transcriptional effects.
The Journal of biological chemistry 20020510
-
Nuclear receptor agonists as potential differentiation therapy agents for human osteosarcoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 20020501
-
Apoptosis induced by activation of peroxisome-proliferator activated receptor-gamma is associated with Bcl-2 and NF-kappaB in human colon cancer.
Life sciences 20020419
-
15-Deoxy-Delta12,14-prostaglandin J2 regulates mesangial cell proliferation and death.
Kidney international 20020401
-
Enhanced growth inhibition by combination differentiation therapy with ligands of peroxisome proliferator-activated receptor-gamma and inhibitors of histone deacetylase in adenocarcinoma of the lung.
Clinical cancer research : an official journal of the American Association for Cancer Research 20020401
-
Peroxisome proliferator-activated receptor-gamma agonists inhibit experimental allergic encephalomyelitis by blocking IL-12 production, IL-12 signaling and Th1 differentiation.
Genes and immunity 20020401
-
Novel 5-substituted 2,4-thiazolidinedione and 2,4-oxazolidinedione derivatives as insulin sensitizers with antidiabetic activities.
Journal of medicinal chemistry 20020328
-
Regulation of cytokine expression by ligands of peroxisome proliferator activated receptors.
Journal of immunology (Baltimore, Md. : 1950) 20020315
-
Dualism of oxidized lipoproteins in provoking and attenuating the oxidative burst in macrophages: role of peroxisome proliferator-activated receptor-gamma.
Journal of immunology (Baltimore, Md. : 1950) 20020315
-
Nimesulide, a preferential cyclooxygenase 2 inhibitor, suppresses peroxisome proliferator-activated receptor induction of cyclooxygenase 2 gene expression in human synovial fibroblasts: evidence for receptor antagonism.
Arthritis and rheumatism 20020201
-
[Thiazolidinediones and PPARgamma system in repair of liver damage].
Recenti progressi in medicina 20020101
-
Peroxisome proliferator-activated receptor gamma ligand inhibits cell growth and invasion of human pancreatic cancer cells.
International journal of gastrointestinal cancer 20020101
-
15-deoxy-delta12,14-prostaglandin J2-induced apoptosis in amnion-like WISH cells.
Prostaglandins & other lipid mediators 20011201
-
Prostaglandin-J2 induces synthesis of interleukin-8 by endothelial cells in a PPAR-gamma-independent manner.
Prostaglandins & other lipid mediators 20011001
-
Stimulated release of arachidonic acid by agonists of the peroxisome proliferator-activated receptor and retinoic acid receptors.
Prostaglandins, leukotrienes, and essential fatty acids 20011001
-
trans-10,cis-12-Conjugated linoleic acid reduces leptin secretion from 3T3-L1 adipocytes.
Biochemical and biophysical research communications 20010921
-
Activation of the PPAR pathway induces apoptosis and COX-2 inhibition in HT-29 human colon cancer cells.
Carcinogenesis 20010901
-
TZDs inhibit vascular smooth muscle cell growth independently of the cyclin kinase inhibitors p21 and p27.
American journal of physiology. Endocrinology and metabolism 20010801
-
Arylhydrocarbon receptor (AhR) is involved in negative regulation of adipose differentiation in 3T3-L1 cells: AhR inhibits adipose differentiation independently of dioxin.
Journal of cell science 20010801
-
Identification of a peroxisome-proliferator-activated-receptor response element in the apolipoprotein E gene control region.
The Biochemical journal 20010715
-
Inhibitors of arachidonic acid metabolism potentiate tumour necrosis factor-alpha-induced apoptosis in HL-60 cells.
European journal of pharmacology 20010713
-
Cloning of the human cholesteryl ester hydrolase promoter: identification of functional peroxisomal proliferator-activated receptor responsive elements.
Biochemical and biophysical research communications 20010622
-
Peroxisome proliferator-activated receptor-gamma regulates airway epithelial cell activation.
American journal of respiratory cell and molecular biology 20010601
-
Involvement of p21(WAF1/Cip1), p27(Kip1), and p18(INK4c) in troglitazone-induced cell-cycle arrest in human hepatoma cell lines.
Hepatology (Baltimore, Md.) 20010501
-
Peroxisome proliferator-activated receptor gamma ligands suppress the transcriptional activation of cyclooxygenase-2. Evidence for involvement of activator protein-1 and CREB-binding protein/p300.
The Journal of biological chemistry 20010413
-
The nuclear receptor PPAR gamma is expressed by mouse T lymphocytes and PPAR gamma agonists induce apoptosis.
European journal of immunology 20010401
-
A cyclopentenone prostaglandin activates mesangial MAP kinase independently of PPARgamma.
Biochemical and biophysical research communications 20010216
-
Delayed activation of PPARgamma by LPS and IFN-gamma attenuates the oxidative burst in macrophages.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 20010201
-
Synergistic potentiation of thiazolidinedione-induced ST 13 preadipocyte differentiation by RAR synergists.
Biochemical and biophysical research communications 20010126
-
Antihyperglycemic activity of new 1,2,4-oxadiazolidine-3,5-diones.
European journal of medicinal chemistry 20010101
-
Down-regulation of uncoupling protein-3 and -2 by thiazolidinediones in C2C12 myotubes.
FEBS letters 20001027
-
Bisphenol A diglycidyl ether (BADGE) is a PPARgamma agonist in an ECV304 cell line.
British journal of pharmacology 20001001
-
PPAR-gamma is selectively upregulated in Caco-2 cells by butyrate.
Biochemical and biophysical research communications 20000607
-
Peroxisome proliferator-activated receptor gamma ligands are potent inhibitors of angiogenesis in vitro and in vivo.
The Journal of biological chemistry 19990326
-
N-(2-Benzoylphenyl)-L-tyrosine PPARgamma agonists. 1. Discovery of a novel series of potent antihyperglycemic and antihyperlipidemic agents.
Journal of medicinal chemistry 19981203
-
A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation.
Cell 19951201
-
Effects of ciglitazone on blood pressure and intracellular calcium metabolism.
Hypertension (Dallas, Tex. : 1979) 19930601